MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11912-026-01824-0

Медицинская библиотека · Current oncology reports · 2026

Artificial Intelligence for Diagnosis, Risk Stratification, and Prognosis of Neuroblastoma - A Systematic Review and Meta-Analysis.

Serbena Daniel Rodrigo, Cieslack Isabela Luiza Fraron, Ratis Renan Cassiano, Chaves Débora Van Putten, de Oliveira Filho Sergio Servilha, Neves Henrique, Dos Santos Fernando Sluchensci, Cassar Daniel Roberto, da Silva Weber Claudio, Bonini Juliana Sartori

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

PURPOSE: To synthesizes evidence on artificial intelligence (AI) performance in neuroblastoma (NB) diagnosis, risk stratification, prognosis, and genomic characterization.

MATERIALS AND

METHODS

A systematic review and meta-analysis was conducted following PRISMA 2020 guidelines (PROSPERO: CRD42024539475) across five databases. Meta-analyses used random-effects models with logit-transformed Area Under the Curve (AUCs) and cluster-robust standard errors. AI models were classified as Machine Learning Models (MLM) or Hybrid Nomograms (HN) based on their construction methodology.

RESULTS

Of 3,742 articles identified, 53 were included. MLMs demonstrated higher point estimates than radiologists in differential diagnosis (AUC: 0.87 vs. 0.83), though this difference was not statistically significant and carried substantial uncertainty. HNs achieved stronger performance in risk stratification (AUC: 0.87). AI-derived nomograms (AUC: 0.9) and gene signatures (AUC: 0.8) outperformed conventional prognostic markers descriptively. Chemotherapy response prediction remained below clinical utility thresholds across all model types. Only 33.9% of models reported calibration and 24.5% underwent external validation.

CONCLUSIONS

AI demonstrates proof-of-concept across multiple NB clinical domains. However, clinical adoption remains premature given persistent gaps in external validation, calibration, dataset size, and pediatric-specific model development. Future studies should test these models prospectively in multicenter pediatric cohorts, ideally through COG or SIOPEN, using shared definitions for diagnosis, risk group, treatment response, and survival outcomes.

Для цитирования: Serbena Daniel Rodrigo, Cieslack Isabela Luiza Fraron, Ratis Renan Cassiano, Chaves Débora Van Putten, de Oliveira Filho Sergio Servilha, Neves Henrique, Dos Santos Fernando Sluchensci, Cassar Daniel Roberto, da Silva Weber Claudio, Bonini Juliana Sartori. Artificial Intelligence for Diagnosis, Risk Stratification, and Prognosis of Neuroblastoma - A Systematic Review and Meta-Analysis.. Current oncology reports. 2026. DOI: 10.1007/s11912-026-01824-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.